Skip to main content

Entwicklungsmöglichkeiten

  • Chapter
Interventionelle Gefäßtherapie

Zusammenfassung

Die Ballonangioplastie hat sich seit ihrer Erstbeschreibung durch Grüntzig [14] als wenig invasives, transluminales Verfahren in einem großen Indikationsspektrum als gleichwertige oder überlegene Methode im Vergleich zu konservativen oder chirurgischen Therapien der chronischen arteriellen Verschlusskrankheit durchgesetzt [10] (siehe auch Kapitel 2.7). Dabei wird die Ballonangioplastie alleine oder in Kombination mit anderen perkutanen transluminalen Verfahren, insbesondere als so genannte „Stentangioplastie`, durchgeführt. Moderne Ballonkatheter sind technisch weit entwickelt, und es steht ein breites Spektrum von Kathetern für unterschiedliche Indikationsgebiete und Ansprüche zur Verfügung. Neben Standardballonkathetern sind Katheter mit schmalem Profil und dünnen Schäften für Interventionen im Unterschenkelbereich, extra widerstandsfähige Ballons für stark verkalkte und exzentrische Steno-sen sowie Ballons mit speziellen Eigenschaften, z. B. für die Stentapplikation, entwickelt worden. Wesentliche Neuentwicklungen sind auf diesem Gebiet nach Ansicht der Autoren nicht zu erwarten. Eine Ausnahme stellen hier neue Ballonkonzepte wie z. B. der cutting balloon dar, auf die weiter unten eingegangen wird. Technische Detailverbesserungen, insbesondere was die Handhabbarkeit, die Sicherheit und Kostengesichtspunkte betrifft, sind aber sicherlich noch zu realisieren. Die Entwicklungsmöglichkeiten der Ballonangioplastie als therapeutisches Verfahren betreffen deswegen mehr klinische Fragestellungen, wie die Verbesserung der Datenlage hinsichtlich bestehender Indikationsgebiete, die Erweiterung des Indikationsspektrums oder die optimale medikamentöse Begleittherapie.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 59.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL (1999) AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: a statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association. Stroke 30:2502–2511

    Article  PubMed  CAS  Google Scholar 

  2. Alike H, Starck E, Caspary L, Renczes J, Alexander K (1996) Angioplastische Therapie der Thrombangitis obliterans unter Einsatz der Perkutanen Aspirations Thrombektomie (PAT) und Thrombolyse. Herz Kreislauf 28:190–194

    Google Scholar 

  3. Becker GJ, Katzen BT, Dake MD (1989) Noncoronary angioplasty. Radiology 170:921–940

    PubMed  CAS  Google Scholar 

  4. Brieger D, Topol E (1997) Local drug delivery systems and prevention of restenosis. Cardiovasc Research 35:405–413

    Article  CAS  Google Scholar 

  5. Bucker A, Neuerburg JM, Adam G, Schürmann K, Rasche V, van Vaals JJ, Molgaard-Nielsen A, Günther RW (1998) Stent placement with real time MRI guidance: initial animal experiment experiences. Fortschr Röntgenstr 169:655–657

    Article  CAS  Google Scholar 

  6. CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 348:1329–1339

    Article  Google Scholar 

  7. Carmenzind E, Kint PP, DiMario C, Ligthart J, van der Giesse W, Boersma E, Serruys PW (1995) Intracoronary heparin delivery in humans. Acute feasibility and long-term results. Circulation 92: 2463–2472

    Article  Google Scholar 

  8. Costa MA, Sabat M, van der Giessen WJ, Kay IP, Cervinka P, Ligthart JM, Serrano P, Coen VL, Levendag PC, Serruys PW (1999) Late coronary occlusion after intracoronary brachytherapy. Circulation 100:789–792

    Article  PubMed  CAS  Google Scholar 

  9. Dichek DA, Neville RF, Zwiebel JA, Freeman SM, Leon MB, Anderson WF (1989) Seeding of intravascular stents with genetically engineered endothelial cells. Circulation 80:1347–1532

    Article  PubMed  CAS  Google Scholar 

  10. Dormandy JA, Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 31:S1–S296 (die Empfehlungen sind auch online verfügbar:http://www.tasc-pad.org/)

    Article  PubMed  CAS  Google Scholar 

  11. EPIC Investigators (1994) Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med 330:956–961

    Article  Google Scholar 

  12. EPISTENT Investigators (1998) Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 352:87–92

    Article  Google Scholar 

  13. Fox R (2001) American Heart Association 2001 scientific sessions: late-breaking science-drug-eluting stents. Circulation 104:E9052

    Google Scholar 

  14. Grüntzig A, Hopff H (1974) Perkutane Rekanalisation chronisch arterieller Verschlüsse mit einem neuen Dilatationskatheter. Dtsch Med Wschr 99: 2502–2505

    Article  PubMed  Google Scholar 

  15. Hall P, Nakamura S, Maiello L, Itoh A, Blengino S, Martini G, Ferraro M, Colombo A (1996) A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 93:215–222

    Article  PubMed  CAS  Google Scholar 

  16. Haudenschild CC (1993) Pathobiology of Restenosis After Angioplasty. Am J Med 94:4A–40S–44S

    Google Scholar 

  17. Hong MK, Wong SC, Farb A, Mehlmann SC, Virmani R, Barry JJ, Leon MB (1993) Feasability and drug delivery efficiency of a new balloon angioplasty catheter capable of performing simultaneous local drug delivery. Coron Artery Dis 4:1023–1027

    Article  PubMed  CAS  Google Scholar 

  18. Ischinger TA (1998) Antithrombotics in interventional cardiology: Optimizing treatment and strategies. Am J Cardiol 82:25L–28L

    Article  PubMed  CAS  Google Scholar 

  19. Kalinowski M, Alfke H, Bergen S, Klose KJ, Barry JJ, Wagner HJ (2001) Comparative trial of local pharmacotherapy with L-arginine, r-hirudin, and molsidomine to reduce restenosis after balloon angioplasty of stenotic rabbit iliac arteries. Radiology 219:716–723

    PubMed  CAS  Google Scholar 

  20. Korogi Y, Hirai T, Takahashi M (1996) Intravascular ultrasound imaging of peripheral arteries as an adjunct to balloon angioplasty and atherectomy. Cardiovasc Intervent Radiol 19:1–9

    Article  PubMed  CAS  Google Scholar 

  21. Ladd ME, Quick HH, Debatin JF (2000) Intervantional MRA and Intravascular Imaging. J Magn Reson Imaging 12:534–546

    Article  PubMed  CAS  Google Scholar 

  22. Lambert CR, Leone JF, Howland SM (1993) Local drug delivery. Functional comparison of porous and microporous design. Coron Artery Dis 5:469–475

    Article  Google Scholar 

  23. Mathias K, Jäger H, Sahl H, Hennigs S, Gißler HM (1999) Die endoluminale Therapie der Karotisstenose. Dt Ärztebl 96:A2502–2508

    Google Scholar 

  24. Matschl V, Heverhagen JT, Kalinowski M, Alfke H, Jaensch HJ, Wagner HJ, Klose KJ (2001) In vivo evaluation of an intravascular receiver coil for MRI at 1.0 Tesla. Vasa 30:9–13

    Article  PubMed  CAS  Google Scholar 

  25. Neuhaus KL, v Essen R, Tebbe U, Jessel A, Heinrichs H, Maurer W, Doring W, Harmjanz D, Kotter V, Kalhammer E (1994) Safety observations from the pilot phase of the randomized r-hirudin for improvement of thrombolysis (HIT III) study. Circulation 90:1638–1642

    Article  PubMed  CAS  Google Scholar 

  26. Nunes GL, Thomas CN, Hanson SR, Barry JJ, King SB, Scott NA (1995) Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel coated balloon. Circulation 92:1697–1700

    Article  PubMed  CAS  Google Scholar 

  27. Park S-W, Lee CW, Hong M-K, Kim J-J, Lee N-H, Park S-J (2000) Role of cutting balloon angioplasty before coronary stent implantation. Am Heart J 139:1–4

    Article  Google Scholar 

  28. Phillips-Hughes J, Kandarpa K (1996) Restenosis: Pathophysiology and Preventive Strategies. J Vasc Intervent Radiol 7:321–333

    Article  CAS  Google Scholar 

  29. Popma JJ, Calioff RM, Topol EJ (1991) Clinical trials of restenosis after coronary angioplasty. Circulation 84:1426–1436

    Article  PubMed  CAS  Google Scholar 

  30. Serruys PW, Kay IP (2000) I like the candy, I hate the wrapper: the (32)P radioactive stent. Circulation 101:3–7

    Article  PubMed  CAS  Google Scholar 

  31. Sousa JE, Costa MA, Abizaid AC, Rensing BJ, Abizaid AS, Tanajura LF, Kozuma K, Van Langenhove G, Sousa AG, Falotico R, Jaeger J, Popma JJ, Serruys PW (2001) Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 104:2007–2011

    Article  PubMed  CAS  Google Scholar 

  32. Spijkerboer AM, Nass PC, de Valois JC, van der Graaf Y, Eikelboom BC, Mali WP (1996) Evaluation of femoropopliteal arteries with duplex ultrasound after angioplasty. Can we predict results at one year? Eur J Vasc Endovasc Surg 12:418–423

    Article  PubMed  CAS  Google Scholar 

  33. Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Sirkin K, Cloutier DA, Leon MB, Tripuraneni P (2000) Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 101:360–365

    Article  PubMed  CAS  Google Scholar 

  34. Tetteroo E, van der Graf Y, Bosch JL, van Engelen AD, Hunink MGM, Eikelboom BC, et al. (1998) Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Lancet 351:1153–1159

    Article  PubMed  CAS  Google Scholar 

  35. Topol EJ, Ferguson JJ, Weismann HF, Tcheng JE, Ellis SG, Kleiman NS, et al. (1997) Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta 3 blockage with percutaneous aoronary intervention. Lancet 278:479–484

    CAS  Google Scholar 

  36. Tyagi S, Verma PK, Gambhir DS, Kaul UA, Saha R, Arora R (1998) Early and long-term results in subclavian angioplasty in aortoarteritis (takayasu disease): comparison with atherosclerosis. Cardiovasc Intervent Radiol 21:219–224

    Article  CAS  Google Scholar 

  37. Unterberg C, Buchwald AB, Barath P, Schmidt T, Kreuzer H, Wiegand V (1993) Cutting balloon angioplasty - initial clinical experience. Clin Cardiol 16:660–664

    Article  PubMed  CAS  Google Scholar 

  38. Wagner HJ, Rager G (1998) Infrapopliteale Angioplastie - die vergessene Region? Fortschr Röntgenstr 168:415–420

    Article  CAS  Google Scholar 

  39. Wildermuth S, Zimmermann GG, Debatin JF (1998) Vaskuläre Applikationen der interventionellen MRT. Radiologe;38:210–217

    Article  PubMed  CAS  Google Scholar 

  40. Whyman MR, Fowkes FGR, Kerrqacher EMG, Gillespie IN, Housley E, Ruckley CV (1997) Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomised controlled trial. J Vasc Surg 26:551–557

    Article  PubMed  CAS  Google Scholar 

  41. Wolinsky H (1994) Local delivery: Let’s keep our eyes on the wall. J Am Coll Cardiol 24:825–827

    Article  PubMed  CAS  Google Scholar 

  42. Yamashita K, Satake S, Ohira H, Ohtomo K (1994) Radiofrequency thermal balloon coronary angioplasty: a new device for successful percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 23:336–340

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Alfke, H., Kalinowski, M., Wagner, HJ. (2002). Entwicklungsmöglichkeiten. In: Vallbracht, C., Roth, FJ., Strauss, A.L. (eds) Interventionelle Gefäßtherapie. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57540-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57540-2_11

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-642-63296-9

  • Online ISBN: 978-3-642-57540-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics